Policies That Could Lead To Korean Biopharma Growth And Competitiveness
Industry Sees Regulatory Science Improvements As Key
Executive Summary
A major South Korean pharma industry association provides multiple policy proposals to the country's new government, which it sees as supporting the sector’s growth and international competitiveness through improved regulatory science and other updated approaches.